PT1151297E - Processos para aumentar as interacções de ligação entre membros de pares de ligação específica - Google Patents

Processos para aumentar as interacções de ligação entre membros de pares de ligação específica Download PDF

Info

Publication number
PT1151297E
PT1151297E PT00905755T PT00905755T PT1151297E PT 1151297 E PT1151297 E PT 1151297E PT 00905755 T PT00905755 T PT 00905755T PT 00905755 T PT00905755 T PT 00905755T PT 1151297 E PT1151297 E PT 1151297E
Authority
PT
Portugal
Prior art keywords
members
methods
binding
specific binding
reactions
Prior art date
Application number
PT00905755T
Other languages
English (en)
Inventor
Leon W M M Terstappen
Paul A Liberti
Galla Chandra Rao
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of PT1151297E publication Critical patent/PT1151297E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Reinforced Plastic Materials (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Die Bonding (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Sampling And Sample Adjustment (AREA)
PT00905755T 1999-01-29 2000-01-27 Processos para aumentar as interacções de ligação entre membros de pares de ligação específica PT1151297E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/240,939 US6551843B1 (en) 1999-01-29 1999-01-29 Methods for enhancing binding interactions between members of specific binding pairs

Publications (1)

Publication Number Publication Date
PT1151297E true PT1151297E (pt) 2010-01-20

Family

ID=22908555

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00905755T PT1151297E (pt) 1999-01-29 2000-01-27 Processos para aumentar as interacções de ligação entre membros de pares de ligação específica

Country Status (11)

Country Link
US (1) US6551843B1 (pt)
EP (1) EP1151297B1 (pt)
JP (2) JP2002535677A (pt)
AT (1) ATE449333T1 (pt)
AU (1) AU2738900A (pt)
CA (1) CA2359664A1 (pt)
DE (1) DE60043335D1 (pt)
DK (1) DK1151297T3 (pt)
ES (1) ES2335080T3 (pt)
PT (1) PT1151297E (pt)
WO (1) WO2000045169A1 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282350B2 (en) 1998-02-12 2007-10-16 Immunivest Corporation Labeled cell sets for use as functional controls in rare cell detection assays
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
BR0017261A (pt) * 2000-07-14 2003-07-29 Immunivest Corp Métodos para isolamento de uma bioentidade alvo de uma amostra biológica e de células de tumor com densidade de antìgeno baixa e, kits para inibir a agregação endógena de partìculas magnéticas coloidais no processamento de material biológico e, para isolamento de células de tumor de densidade de antìgeno baixa de uma amostra biológica com agregação ontrolada de partìculas magnéticas coloidais
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
AU2003219759B2 (en) 2002-02-14 2011-01-20 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US7764821B2 (en) 2002-02-14 2010-07-27 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
WO2004076643A2 (en) 2003-02-27 2004-09-10 Immunivest Corporation CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
WO2006023563A2 (en) 2004-08-17 2006-03-02 Immunivest Corporation A diagnostic imaging device for the analysis of circulating rare cells
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
EP1848831A4 (en) * 2005-01-13 2008-11-05 Novartis Vaccines & Diagnostic ELISA TESTS USING PRION-SPECIFIC PEPTIDE REAGENT
US7777885B2 (en) * 2005-08-17 2010-08-17 Veridex, Llc Diagnostic imaging device for the analysis of circulating rare cells
JP5209477B2 (ja) 2005-09-09 2013-06-12 ノバルティス アーゲー プリオンに特異的なペプトイド試薬
US8337755B2 (en) * 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
CN101583722A (zh) 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
US8110101B2 (en) * 2007-08-30 2012-02-07 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US20090061456A1 (en) * 2007-08-30 2009-03-05 Allard William J Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
US7828968B2 (en) * 2007-08-30 2010-11-09 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US20090117532A1 (en) * 2007-11-01 2009-05-07 Doyle Gerald V Pre-clinical method for monitoring serial changes in circulating breast cancer cells in mice
MX2010005811A (es) * 2007-11-27 2010-06-09 Veridex Llc Enumeracion automatica y caracterizacion de las celulas del melanoma circulantes en la sangre.
WO2009076560A2 (en) * 2007-12-12 2009-06-18 The Board Of Trustees Of The Leland Stanford Junior University Method and apparatus for magnetic separation of cells
US20090191535A1 (en) * 2007-12-22 2009-07-30 Mark Carle Connelly Method of assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
KR101384142B1 (ko) * 2007-12-28 2014-04-14 삼성디스플레이 주식회사 표시기판, 이의 제조방법 및 이를 갖는 표시장치
WO2009100137A2 (en) * 2008-02-04 2009-08-13 University Of Miami Magnetic cells for localizing delivery and tissue repair
CN102083450A (zh) * 2008-04-30 2011-06-01 诺华有限公司 致病性构象异构体的分析
RU2530715C2 (ru) * 2008-10-16 2014-10-10 Конинклейке Филипс Электроникс Н.В. Способ и устройство для определения количества магнитно меченных целевых компонентов
WO2010068812A1 (en) 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
US20120077246A1 (en) * 2009-04-24 2012-03-29 The Board Of Trustees Of The University Of Illinoi Methods and Devices for Capturing Circulating Tumor Cells
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
CN102725639A (zh) 2009-11-04 2012-10-10 诺华有限公司 蛋白质聚集物与单体分离中作为结合试剂的带正电物质
CA2791905A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarkers for theranostics
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
KR101212029B1 (ko) * 2011-12-20 2012-12-13 한국기초과학지원연구원 화합물 결합단백질 검출 방법
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
EP3114484A4 (en) 2014-03-07 2017-08-30 The Board of Trustees of the University of Illionis Biomimetic microfluid device for capturing circulating tumor cells
CN107884562B (zh) 2016-09-30 2020-10-16 爱科来株式会社 粒子的磁标记方法和标记装置
JP6754345B2 (ja) * 2016-09-30 2020-09-09 アークレイ株式会社 粒子の磁気標識方法及び標識装置
US11413378B2 (en) 2018-05-08 2022-08-16 Biomagnetic Solutions Llc Rigid chamber for cell separation from a flexible disposable bag
EP3693739A1 (de) * 2019-02-06 2020-08-12 Stefan Schreier Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018886A (en) 1975-07-01 1977-04-19 General Electric Company Diagnostic method and device employing protein-coated magnetic particles
US3970518A (en) 1975-07-01 1976-07-20 General Electric Company Magnetic separation of biological particles
US4267234A (en) 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4375407A (en) 1981-06-22 1983-03-01 The Franklin Institute High gradient magnetic separation device
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US4847193A (en) * 1987-06-18 1989-07-11 Gene-Trak Systems Signal amplification in an assay employing a piezoelectric oscillator
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
US5186827A (en) 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
WO1996007101A1 (en) * 1994-08-31 1996-03-07 First Medical, Inc. Quantitative assays employing magnetizable particles for rate enhancement
EP0810905B1 (en) 1995-02-21 1998-11-04 Iqbal W. Dr. Siddiqi Apparatus and method for mixing and separation employing magnetic particles
JPH08313539A (ja) * 1995-05-16 1996-11-29 Nittec Co Ltd 容器およびこの容器を用いた液体撹拌・洗浄・磁性体微粒子捕集方法並びに該容器を用いた免疫化学検査装置
US5985153A (en) * 1996-06-07 1999-11-16 Immunivest Corporation Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
DE69939955D1 (de) * 1998-07-01 2009-01-02 Takara Bio Inc Methoden für Gentransfer mit Retroviren

Also Published As

Publication number Publication date
EP1151297A1 (en) 2001-11-07
EP1151297A4 (en) 2003-04-09
CA2359664A1 (en) 2000-08-03
DK1151297T3 (da) 2010-03-01
JP2010261963A (ja) 2010-11-18
ES2335080T3 (es) 2010-03-22
US6551843B1 (en) 2003-04-22
WO2000045169A1 (en) 2000-08-03
ATE449333T1 (de) 2009-12-15
JP2002535677A (ja) 2002-10-22
AU2738900A (en) 2000-08-18
DE60043335D1 (de) 2009-12-31
JP5442544B2 (ja) 2014-03-12
EP1151297B1 (en) 2009-11-18
WO2000045169A9 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
EP1151297A4 (en) METHODS FOR ENHANCING BINDING INTERACTIONS BETWEEN SPECIFIC BINDING PAIR ELEMENTS
PT1042496E (pt) Processo de preparacao enzimatica de homogentisato
AU7013401A (en) Methods for enhancing antibody-induced cell lysis and treating cancer
AU7503901A (en) Improved nucleic acid modifying enzymes
CA2241774A1 (en) Process for making a cyclodextrin
MX223544B (es) Metodo para reaccionar un compuesto organico con un hidroperoxido.
WO2000012726A3 (en) Rationally designed heparinases derived from heparinase i and ii
BG107861A (en) Isothermal amplification of nucleic acids on a solid support
EP0976829A3 (en) Protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof
AU5850200A (en) Positive plate active material, method for producing the same, and secondary cell
DK0675951T3 (da) Enzym med endoglucanaseaktivitet
BR9916848A (pt) Processo para produzir intermediários de ácido ascórbico
NZ514230A (en) A single step method for lysing cells and cleaving a fusion protein
WO2003055975A3 (en) A method for engineering strand-specific, sequence-specific, dna-nicking enzymes
YU68900A (sh) Kombinacije inhibitora protein farnesiltransferaze i hmg coa reduktaze i njihova upotreba u tretmanu raka
DE60222390D1 (de) Verbessertes in-vitro-synthesesystem
AU1908100A (en) Isothermal nucleic acid amplification methods
WO2002083932A3 (de) Enzymabbauketten
WO2003050265A3 (en) Compositions and methods for normalizing assays
WO2002031121A3 (en) Improvement of endothelial cell-cell cohesion
AU2001235938A1 (en) Method for increasing the performance of immobilized biocatalysts, and catalystsobtained thereby
IL137197A0 (en) Modulation of cell proliferation, methods and reagents
WO1996007730A3 (de) Chemisches verfahren zur förderung der proliferation von tierischen zellen
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
AU2002346403A1 (en) Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking